IL13 and atopic eczema: ,49 To get insight into the mechanism of the decline in OBP2A expression in atopic dermatitis lesional skin, we measured changes in OBP2A expression in human keratinocytes treated with type 2 cytokine IL-4 or IL-13, known to be involved in the pathogenesis of atopic dermatitis.50